Covered recipient · General Payments record
BRITTANY CINDA TILSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$437.36
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $409.87 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $214.80 | 11 |
| Amgen Inc. | $87.03 | 3 |
| DEXCOM, INC. | $32.00 | 1 |
| GlaxoSmithKline, LLC. | $23.56 | 1 |
| Xeris Pharmaceuticals, Inc. | $17.72 | 1 |
| Organon LLC | $17.69 | 1 |
| Merck Sharp & Dohme Corporation | $17.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $27.87 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117399076 | CMS |
| Amgen Inc. | $26.93 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117399078 | CMS |
| Amgen Inc. | $32.23 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117399080 | CMS |
| Dexcom, Inc. | $32.00 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153288811 | CMS |
| GlaxoSmithKline, LLC. | $23.56 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115814605 | CMS |
| Merck Sharp & Dohme LLC | $17.07 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141907144 | CMS |
| Novo Nordisk Inc | $22.06 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108580753 | CMS |
| Novo Nordisk Inc | $20.07 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108580603 | CMS |
| Novo Nordisk Inc | $20.07 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108581707 | CMS |
| Novo Nordisk Inc | $24.91 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108580111 | CMS |
| Novo Nordisk Inc | $11.09 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108581463 | CMS |
| Novo Nordisk Inc | $19.42 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108581661 | CMS |
| Novo Nordisk Inc | $20.15 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108582441 | CMS |
| Novo Nordisk Inc | $23.12 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108582785 | CMS |
| Novo Nordisk Inc | $18.74 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108582581 | CMS |
| Novo Nordisk Inc | $19.63 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108583441 | CMS |
| Novo Nordisk Inc | $15.54 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108583341 | CMS |
| Organon Llc | $17.69 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136309635 | CMS |
| Xeris Pharmaceuticals, Inc. | $17.72 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144589286 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.